Triple-negative breast cancer (TNBC) takes up about 15% of all breast cancers and lacks estrogen receptor and progesterone receptor expression as well as human epidermal growth factor receptor 2 (HER2) amplification. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.